SBRT for oligoprogressive disease: using the evidence to maximise the benefits

Lancet. 2024 Jan 13;403(10422):122-124. doi: 10.1016/S0140-6736(23)02351-6. Epub 2023 Dec 14.

Authors

Gerard G Hanna¹, Fiona McDonald²

Affiliations

¹ Department of Oncology, Belfast Health and Social Care Trust, Belfast BT9 7AB, UK; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK. Electronic address: g.hanna@qub.ac.uk.
² Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, UK.

PMID: 38104574
DOI: 10.1016/S0140-6736(23)02351-6

No abstract available

Publication types

Comment

MeSH terms

Disease Progression
Humans
Lung Neoplasms* / surgery
Radiosurgery*
Retrospective Studies